ArchVelo reveals distinct differentiation trajectories in immune cells using scATAC-seq and scRNA-seq, suggesting new insights into gene regulation.
Inferring dynamic cellular processes from static single-cell measurements remains a central challenge in genomics. Here we introduce ArchVelo, a new method for modeling gene regulation and inferring cell trajectories using single-cell simultaneous chromatin accessibility (scATAC-seq) and transcriptomic (scRNA-seq) profiling. ArchVelo represents chromatin accessibility as a set of archetypes---shared regulatory programs---and models their dynamic influence on transcription. Compared to previous methods, ArchVelo improves inference accuracy and gene-level latent time alignment, and enables identification of the underlying transcription factor activity. We benchmark ArchVelo on developing mouse brain and human hematopoiesis datasets and apply it to CD8 T cells responding to viral infection, revealing distinct trajectories of differentiation and proliferation. Focusing on the progenitor CD8 T cell population with key roles in sustaining immune responses and translationally linked to immunotherapy outcomes, we identify a previously uncharacterized differentiation trajectory from Ccr6- to Ccr6+ progenitors, shared between acute and chronic infection. In sum, ArchVelo provides a principled framework for modeling dynamic gene regulation in multi-omic single-cell data across biological systems.
No takes yet. Share an insight, caveat, or question.
Avdeeva et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: